A detailed history of Financial Planning & Information Services, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Financial Planning & Information Services, Inc. holds 1,822 shares of ABBV stock, worth $327,103. This represents 0.05% of its overall portfolio holdings.

Number of Shares
1,822
Previous 1,818 0.22%
Holding current value
$327,103
Previous $311,000 15.43%
% of portfolio
0.05%
Previous 0.05%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$163.84 - $199.33 $655 - $797
4 Added 0.22%
1,822 $359,000
Q2 2024

Aug 13, 2024

SELL
$154.79 - $180.76 $53,712 - $62,723
-347 Reduced 16.03%
1,818 $311,000
Q1 2024

May 14, 2024

BUY
$159.82 - $182.1 $1,598 - $1,821
10 Added 0.46%
2,165 $394,000
Q3 2023

Nov 14, 2023

BUY
$133.59 - $154.65 $667 - $773
5 Added 0.23%
2,155 $321,000
Q2 2023

Aug 11, 2023

BUY
$132.51 - $164.9 $662 - $824
5 Added 0.23%
2,150 $289,000
Q1 2023

May 02, 2023

SELL
$144.61 - $166.54 $75,341 - $86,767
-521 Reduced 19.54%
2,145 $341,000
Q3 2022

Oct 25, 2022

SELL
$134.21 - $153.93 $6,307 - $7,234
-47 Reduced 1.73%
2,666 $358,000
Q1 2022

Apr 19, 2022

SELL
$131.98 - $163.75 $3,959 - $4,912
-30 Reduced 1.09%
2,713 $440,000
Q2 2021

Jul 29, 2021

SELL
$105.21 - $117.21 $11,257 - $12,541
-107 Reduced 3.75%
2,743 $309,000
Q1 2021

Apr 20, 2021

BUY
$102.3 - $112.62 $21,176 - $23,312
207 Added 7.83%
2,850 $308,000
Q3 2020

May 24, 2021

BUY
$85.91 - $100.83 $227,060 - $266,493
2,643 New
2,643 $232,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $317B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Financial Planning & Information Services, Inc. Portfolio

Follow Financial Planning & Information Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Planning & Information Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Financial Planning & Information Services, Inc. with notifications on news.